Related Experiment Videos
Transdermal clonidine: does it affect pain after abdominal hysterectomy?
P Dimou1, A Paraskeva, K Papilas
1Department of Anesthesia, St Savas Hospital, Athens.
Acta Anaesthesiologica Belgica
|November 6, 2003
Summary
Clonidine demonstrated a weak opioid-sparing effect 24 hours after abdominal hysterectomy, reducing analgesic needs but not impacting long-term pain management.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Clonidine is known for its analgesic properties.
- Perioperative pain management is crucial for patient recovery after surgery.
Purpose of the Study:
- To evaluate the perioperative analgesic effect of clonidine in patients undergoing abdominal hysterectomy.
- To assess the impact of clonidine on pain scores and analgesic consumption.
Main Methods:
- Forty patients were randomized into two groups: transdermal clonidine plus overlay (CLO) or overlay alone (CTL).
- Both groups received intravenous clonidine or saline before induction, followed by standardized anesthesia and postoperative analgesia protocols.
- Pain was assessed using a Visual Analog Scale (VAS) at multiple time points, and hemodynamic parameters were monitored.
Main Results:
- Arterial blood pressure was transiently lower in the clonidine group post-intubation.
- No significant differences in pain or fentanyl consumption were observed within the first 8 hours postoperatively.
- The clonidine group required fewer analgesics at 24 hours (p = 0.023), indicating a short-term opioid-sparing effect.
Conclusions:
- Clonidine provided a weak opioid-sparing effect 24 hours postoperatively in patients undergoing abdominal hysterectomy.
- Clonidine did not significantly alter long-term pain perception or analgesic requirements at 72 hours and 30 days.